Recrutamento encerrado
FASE
Número Europeu 2014-000722-38
INNOVATION-TRIAL
INtegratioN of Trastuzumab, With or Without Pertuzumab, Into periOperatiVe chemotherApy of HER-2 posiTIve stOmach caNcer: the INNOVATION-TRIAL
Detalhes
Destaques